Our founders’ insights and achievements

NuMat Medtech secures a €530,000 round of investment

Minoryx Therapeutics raises €21.3M in Series B funding round

QIAGEN enters into agreement to acquire STAT-Dx, a Caixa Capital Risc portfolio company

MedLumics, a company owned by “la Caixa” and Ysios Capital, closes a financing round of 34.4 million euros

Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102

Stat Diagnostica announces 25 Million Euros in Series C Financing

”la Caixa” leads an investment round in Inbiomotion with the participation of Ysios Capital

Minoryx Therapeutics appoints Dr. Khalid Islam as chairman of the board of directors

Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine